Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Current Assets: 2021-2025

Historic Current Assets for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $5.0 billion.

  • Roivant Sciences' Current Assets fell 22.23% to $4.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 billion, marking a year-over-year decrease of 22.23%. This contributed to the annual value of $5.0 billion for FY2025, which is 25.73% down from last year.
  • As of FY2025, Roivant Sciences' Current Assets stood at $5.0 billion, which was down 6.78% from $5.4 billion recorded in FY2024.
  • Over the past 5 years, Roivant Sciences' Current Assets peaked at $6.8 billion during FY2023, and registered a low of $1.6 billion during FY2022.
  • Over the past 3 years, Roivant Sciences' median Current Assets value was $5.4 billion (recorded in 2024), while the average stood at $5.1 billion.
  • In the last 5 years, Roivant Sciences' Current Assets fell by 28.03% in 2022 and then soared by 313.47% in 2023.
  • Roivant Sciences' Current Assets (Yearly) stood at $2.2 billion in 2021, then reached $2.3 billion in 2021, then decreased by 1.85% to $2.1 billion in 2022, then decreased by 28.03% to $1.6 billion in 2022, then fell by 16.21% to $1.8 billion in 2023, then surged by 313.47% to $6.8 billion in 2023, then skyrocketed by 274.28% to $6.7 billion in 2024, then dropped by 21.20% to $5.4 billion in 2024, then decreased by 25.73% to $5.0 billion in 2025.